Navigation Links
APhA Announces Plans for Executive Leadership Transition
Date:3/18/2008

SAN DIEGO, March 18 /PRNewswire-USNewswire/ -- The American Pharmacists Association (APhA) announced that it has been actively working on plans for an executive leadership transition. During the final session of the APhA 2008 Annual Meeting & Exposition House of Delegates, John A. Gans, PharmD, Executive Vice-President and Chief Executive Officer announced that his time in his current position with the Association will be coming to an end in 2009, after nearly 20 years of service to the organization.

Gans has been APhA's Executive Vice-President and Chief Executive Officer since 1989. Prior to joining APhA, Gans served on the faculty and was Dean of the School of Pharmacy at the Philadelphia College of Pharmacy and Science, where he earned his pharmacy degree in 1966 and his doctorate in pharmacy in 1969.

"I am proud of my years of service to patients and the pharmacy profession. Leading APhA for almost 20 years has been a sincere privilege and honor. Also, I am very proud that APhA continues to identify, create and support opportunities for pharmacists to make a difference in the lives of patients," said Gans.

"I believe that 2009 is the right time for a leadership transition for a number of reasons. The Association is operationally sound, has a superb staff and is well positioned for continued success. The pharmacy profession is poised to expand our services through programs such as medication therapy management (MTM), which allows pharmacists to work more closely with patients and other health care professionals to improve medication use and advance patient care. And, the Association will move into its new headquarters building on the National Mall in 2009 and showcase to all the strength of the profession of pharmacy and of the Association.

"For the last two decades, Dr. Gans has provided valuable leadership for APhA," said Timothy L. Tucker, president of APhA. "On behalf of the APhA Board of Trustees, I recognize John's significant leadership and accomplishments over a demanding period for APhA and the profession. He has been instrumental in facilitating opportunities for pharmacists to provide patient-focused care, leading efforts to move pharmacists toward a viable patient care model for the future, creating collaborations among professional pharmacy organizations, and raising pharmacists' stature with the government, payers and other health care entities.

"As we embark upon our search for a new leader for APhA, we look forward to building on Dr. Gans' legacy, and to leading APhA and the profession to even higher levels of achievement," said Tucker.

The Board has retained The Miles LeHane Company to manage the search for a replacement for Dr. Gans. The plan calls for the executive leader to be in place by early 2009. Additional information can be found at http://www.aphaceosearch.com.

About the American Pharmacists Association

The American Pharmacists Association, founded in 1852 as the American Pharmaceutical Association, represents more than 63,000 practicing pharmacists, pharmaceutical scientists, student pharmacists, pharmacy technicians, and others interested in advancing the profession. APhA, dedicated to helping all pharmacists improve medication use and advance patient care, is the first-established and largest association of pharmacists in the United States.


'/>"/>
SOURCE American Pharmacists Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... ... human performance, is proud to announce that it has received 510(k) clearance from ... the MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling ...
(Date:4/25/2017)... (PRWEB) , ... April 25, ... ... based in Newport Beach, California, committed to raising awareness for Duchenne muscular ... results from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial ...
(Date:4/25/2017)... BC (PRWEB) , ... April 25, 2017 , ... The ... from Richmond, BC, who live with dental fear and require sedation to receive dental ... at ease during various procedures, from hygienic cleanings to oral surgery, at their ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... unveiling cutting-edge birth defects research related to Zika virus during pregnancy, as well ... society for this important science. , The Teratology Society is ...
(Date:4/25/2017)... Clara, CA (PRWEB) , ... April 25, 2017 ... ... announces the addition of predictive analytics to its patient care management module. Using ... compliance even before a patient has been initiated on continuous positive airway pressure ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
(Date:4/19/2017)... SAN DIEGO , April 19, 2017 /PRNewswire/ ... ("Sorrento"), an antibody-centric, clinical-stage biopharmaceutical company developing new ... today announced the closing of its previously announced ... common stock at a public offering price of ... commissions and estimated offering expenses payable by Sorrento.  ...
(Date:4/18/2017)... -- Cardinal Health (NYSE: CAH ) today is ... share (EPS) guidance and providing a preliminary view on ... this morning,s announcement of the planned acquisition of Medtronic,s ... Cardinal Health now believes that fiscal 2017 ... bottom of its previous guidance range of $5.35 to ...
Breaking Medicine Technology: